Yun Yen

USPTO Granted Patents = 23 (Patent Applications = 13)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 9 (Patent Applications = 12)

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 104(Granted Patents)

Location History:

Arcadin, CA (US) (2017)
Arcadia, CA (US) (2007 - 2024)

Company Filing History:

Calgent Biotechnology Co., Ltd.

patents

4 out of 133

Taipei Medical University

patents

4. 3 out of 13

Stembios Technologies, Inc.

patents

5. 1 out of 16

Anp Technologies, Inc.

patents

6. 1 out of 1

Fulgent Therapeutics, Inc.

patent

7. 1 out of 181

National Health Research Institutes

patents

8. 1 out of 1

Fulgent Genetics, Inc.

patent

9. 2 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2007-2025

Loading Chart...

23 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12453708 - Aminonaphthoquinone compounds for treatment and/or prevention of fibrosis diseases (2025-10-28),

2. 12396962 - Nanoparticles containing a taxane and their use (2025-08-26),

3. 11919858 - Aminonapthoquinone compounds and pharmaceutical composition for blocking ubiquitination-proteasome system in diseases (2024-03-05),

4. 11833122 - Aminonaphthoquinone compounds for treatment and/or prevention of fibrosis diseases (2023-12-05),

5. 11801230 - Nanoparticles containing a taxane and their use (2023-10-31),

6. 11084786 - Compounds and pharmaceutical composition associated with ubiquitination-proteasome system (2021-08-10),

7. 10745433 - Compounds for inhibiting cancer and virus (2020-08-18),

8. 10745350 - Compounds and pharmaceutical composition associated with ubiquitination-proteasome system (2020-08-18),

9. 10624897 - Chlorobenzene substituted azaaryl compounds (2020-04-21),

10. 10577328 - Aminonapthoquinone compounds and pharmaceutical composition for blocking ubiquitination-proteasome system in diseases (2020-03-03),

11. 10246455 - Histone deacetylase inhibitors (2019-04-02),

12. 10201530 - Treatment of BRCA1-defective cancer or resistant cancers (2019-02-12),

13. 10072294 - Ultra-high sensitive monitoring of early transplantation failure (2018-09-11),

14. 9931322 - Treatment of BRCA1-defective cancer or resistant cancers (2018-04-03),

15. 9810684 - Method for increasing number of stem cells in human or animal bodies (2017-11-07),

Title: Inventor Yun Yen - Pioneering Innovations in Arcadia, CA

Introduction: Yun Yen is a visionary inventor based in Arcadia, CA, known for his groundbreaking contributions to the field of technology and beyond.

Latest Patents: Yun Yen holds several patents in various industries, including telecommunications, renewable energy, and healthcare, showcasing his diverse range of expertise and innovative spirit.

Career Highlights: With a career spanning over two decades, Yun Yen has worked with leading research institutions and tech companies, consistently pushing the boundaries of what is possible through his inventive solutions.

Collaborations: Throughout his career, Yun Yen has collaborated with top engineers, scientists, and designers, fostering a culture of creativity and excellence in all his projects.

Conclusion: Inventor Yun Yen's relentless pursuit of innovation and his passion for creating a better future make him a true pioneer in the world of inventions.

This text is generated by artificial intelligence and may not be accurate.